Germany has reached a new daily high and is examining a fourth dose vaccine

German health officials have registered 236,120 new coronavirus infections in the last 24 hours, a new daily high, while the Permanent Vaccine Commission (Stico) is exploring the possibility of prescribing a fourth dose of the vaccine.

The previous daily high was 203,136 new cases and reached a week ago.

The overall incidence reached a new record of 1,283.2 new infections per 100,000 people in seven days, compared to 1,227.5 on Wednesday, 1,017.4 a week ago and 232.4 a month ago, according to data from the Robert Koch Institute (RKI updated). As of Wednesday.

In addition, 164 people died with Covit-19 in 24 hours, up from 188 a week earlier, bringing the total death toll from the epidemic to 118,334.

Since the outbreak, 10,422,764 people have tested positive for SARS-CoV-2, with 2,435,300 currently active cases, and 7,869,200 recovering from the disease.

The total rate of hospital admissions in seven days was 4.77 per 100,000 population, while those in the intensive care unit of Covid-19 patients accounted for 10% of the adult beds.

As of Tuesday, 75.8% (63.1 million people) of the population had been vaccinated, 74.1% (61.6 million) with full terms, and 53.3% (44.3 million) had already received the booster dose.

Currently, 24.2% (20.1 million people) of the German population have not yet been vaccinated: 4 million people under the age of four (4.8%), who are not yet vaccinated.

Speaking to Funke Media Group, Stico Chairman Thomas Mertens said the Vaccine Commission on Wednesday discussed recommending a second booster dose of one of the vaccines based on mRNA technology.

See also  Russian celebrities have destroyed channel bags against russophobia.

“Recent reports from Israel indicate that the fourth dose provides some improvement in defense against infections and significant improvement in protection against the spread of serious illness,” he said, adding that Stico expects to make a recommendation in this regard soon.

Leave a Reply

Your email address will not be published. Required fields are marked *